Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>Events>This Event
  Events - January 2013

European Pre-Filled Syringes

28 Jan 2013 - 29 Jan 2013 - London, UK

Bookmark and Share

SMi are proud to present the return of their flagship Pre-Filled Syringes Conference. Now in its 5th year, the 2013 conference will bring together experts from a range of industry perspectives to discuss solutions and strategies within key issues such as syringe formulations for biosimilars and other biologics, extractable and leachables, primary packaging developments and filling and finishing. As well as exclusive presentations on the latest commercial and regulatory developments across Europe and further afield, the event will act as a unique forum for attendees to learn, make connections and explore new ideas.

**New for 2013: First 25 Pharmaceutical Companies register for £899 including Networking Dinner at the Gilgamesh**


Explore the challenges for the development of HCLF biologics with key industry professionals

Consider the effects of leachables and extractables and evaluating interactions between formulation and containers

Develop your understanding of regulatory compliance from pharmaceutical companies and the MHRA

Hear from leading healthcare professionals on the growing use of pre-filled syringes at the patient ‘front line’

Streamline the filling and closing process by exploring facility design strategies and syringe development line techniques

Discuss the latest in vendor procurement and outsourcing strategies

Network with and learn from key industry professionals, leading academics and healthcare representatives

Visit our website here:

Alternatively Contact Fateja Begum on telephone +44 (0) 20 7827 6184 or email on

Further information
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Promising Drug Combination for Advanced Prostate Cancer
A new drug combination may be effective in treating men with metastatic prostate cancer. Preliminary results of this new approach are encouraging and have led to an ongoing international study being conducted in 196 hospitals worldwide.
A Cellular Symphony Responsible for Autoimmune Disease
Broad Institute researchers have used a novel approach to increase our understanding of the immune system as a whole.
When it Comes to Breast Cancer, Common Pigeon is No Bird Brain
If pigeons went to medical school and specialized in pathology or radiology, they’d be pretty good at distinguishing digitized microscope slides and mammograms of normal vs. cancerous breast tissue, a new study has found.
Editing of LIMS Data Made Faster and More Efficient in Matrix Gemini
The latest version of the Matrix Gemini LIMS (Laboratory Information Management System) from Autoscribe Informatics now provides faster and more efficient editing of LIMS data by eliminating the need for a second editing screen.
University of Edinburgh, Selcia Achieve Key Milestones in Drug Development Program
Scientists from the University of Edinburgh, working with Selcia, have successfully passed the 20-month milestone targets of a 30-month Wellcome Trust SDDi £2.5 million project to design novel treatments for sleeping sickness.
Red Clover Genome to Help Restore Sustainable Farming
The Genome Analysis Centre (TGAC) in collaboration with IBERS, has sequenced and assembled the DNA of red clover to help breeders improve the beneficial traits of this important forage crop.
How a Genetic Locus Protects Adult Blood-Forming Stem Cells
Mammalian imprinted Gtl2 protects adult hematopoietic stem cells by restricting metabolic activity in the cells' mitochondria.
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
New Tech Vastly Improves CRISPR/Cas9 Accuracy
A new CRISPR/Cas9 technology developed by scientists at UMass Medical School is precise enough to surgically edit DNA at nearly any genomic location, while avoiding potentially harmful off-target changes typically seen in standard CRISPR gene editing techniques.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos